FitBiomics Announces Monumental Advancement in Biome Research Poised to Transform Sleep and Gut Health Interventions Worldwide

Microbiome journal publishes peer-reviewed landmark study

NEW YORK, Jan. 7, 2025 /PRNewswire/ -- FitBiomics, a leading biotechnology company using microbiome innovation to create next-generation probiotics, announced today the release of its latest research on the sleep-exercise-microbiome nexus. The landmark proof-of-concept study, published by the journal Microbiome, examined the effects of Lactobacillus bacteria on elite athletes and the general population. FitBiomics' research concludes that athlete-derived probiotics contained in its product, Nella, improve non-athlete wellness. This marks the first-ever probiotic/microbiome intervention clinically validated to improve gut and sleep health, together. Click here to view the full study.

"This publication not only underscores FitBiomics' commitment to advancing science-backed wellness solutions through peer reviewed validation; it also marks a new chapter in our ability to rapidly translate the microbial attributes of the most fit people in the world into preventative medicine solutions to benefit everyone," said Dr. Jonathan Scheiman, Co-founder and CEO of FitBiomics. "Our research shows the profound impact of Nella on the microbiome outside of just 'the gut,' with brain and immune benefits. We are excited to publish the impact of Nella on improving a person's quality of life and longevity by aiding with sleep, while also increasing energy and improving gastrointestinal function—all crucial factors in achieving optimal health and daily performance."

Topline findings of the study include:

• Study participants given a novel probiotic, containing multiple strains of athlete-derived Lactobacillus bacteria, reported a 69% increase in sleep quality, a 31% increase in energy level, and a 37% improvement in bowel movement regularity when compared to other participants given a placebo.
• Researchers observed changes in blood biomarkers indicating reduced oxidative stress and improved recovery from physical strain, and further analysis showed distinct changes in microbial community composition and function associated with the observed effects.
• This new research suggests that gut microbes could be harnessed to improve the wellbeing of people with a less active lifestyle.

In 2021, FitBiomics introduced its first consumer product under the brand Nella. Developed with the company's patented next-generation Lactobacillus probiotic strains, Nella is a probiotic designed for anyone looking for improved sleep quality, more energy and better digestion.

These groundbreaking discoveries are the result of technology developed and spun out of Harvard's prestigious Wyss Institute, where researchers studied the microbiome of elite athletes. To learn more about FitBiomics' latest research on Nella and view the video abstract, click here. For interviews, and additional information, please contact [email protected]. 

About FitBiomics
FitBiomics is a leading biotechnology company that is enhancing human health and wellness by decoding the microbiome of the most fit and healthy people in the world, then translating that biological information into next-generation nutrition. The company has a bold vision to fundamentally change the way we understand and optimize our bodies by accelerating innovations into the global wellness economy. Based on cutting-edge findings from the Wyss Institute for Biologically Inspired Engineering at Harvard and dedicated to promoting health equity, FitBiomics has created a suite of clinically validated products to address significant consumer health concerns. The company's first two products are Nella and V•Nella. Nella is designed to support better digestion and sleep, while V•Nella is designed to reduce fatigue and promote energy and endurance, with more products to come from their innovation platform. For more information visit: https://FitBiomics.com/

Media Contact:

Corinne Fitamant
Goodman Media International for FitBiomics
[email protected]

SOURCE FitBiomics